Future-proofing Clinical Trials Management with Digital Labels and Smart Packaging

1
FUTURE-PROOFING CLINICAL TRIALS MANAGEMENT WITH
DIGITAL LABELS SMART PACKAGING
2
GROWING AT A CAGR OF 5.7, the global clinical
trials industry is set to be worth 65.2 billion
by 2025 as per Grand View Research, Inc. Under
the constant stress of a myriad of challenges
like complex research designs, stringent and
ever-changing regulations, greater demands for
consumer transparency, packaging and printing as
well as RD in a highly competitive environment
to test and launch authentic and effective drugs,
Life science companies need to look for solutions
to refine clinical trials management. With
millions of people connected through their
smartphone's to the internet and consuming
digital information in vast quantities, they may
already have a readily available platform to
capitalize on. Technology could serve as the
answer to rein in the rising costs incurred due
to the various challenges as well as trim and
polish up the supply chain. Digital labels
enabled drugs with smart packaging is one
upcoming technology which could help improve
efficiencies with clinical trials management.
3
ENABLING CLINICAL TRIALS DRUGS AS SMART PRODUCTS
Smartening up drug products involves enabling
them to be connected to the internet through Data
matrix codes and an assigned IoT / internet ID
and creating a digital twin for each product
which can be used to send or receive information
about the drug to patients or healthcare
professionals. Accessible through any
internet-enabled device, these codes on scanning
trigger a digital interaction which takes the
patient or participant to a product specific page
often referred to as a digital label or
electronic label. With a digital identity in
place, a vast number of digital interactions are
made possible.
DIGITAL TWIN
4
SO WHAT KIND OF DIGITAL INTERACTIONS ARE WE
TALKING ABOUT AND HOW WILL THEY HELP STREAMLINE
CLINICAL TRIALS MANAGEMENT?
5
IMPROVED HEALTH LITERACY AND SAFER CONSUMPTION
PRACTICES
The sea of tiny text containing complex
instructions and medical jargon on drug packaging
can be baffling for many to comprehend. Lack of
proficiency in one language could also prevent
many from accessing correct medical information,
leading to miscommunication and life-threatening
risks. Clear and concise information is the key
to improved health literacy and making better
health decisions, and digitizing label content
could provide a massive boost in this
direction. Designing attractive and easy to
understand formats to convey relevant
information, like expiry dates and dosage
instructions using colour codes without worrying
about lack of physical space on packaging,
becomes a possibility through digital labels.
Digital labeling provides a faster and smarter
alternative to leafing through pages and pages of
a booklet. Simple animations can also be
incorporated to deliver relevant instructions,
eliminating the language barrier factor.
6
RICHER AND MORE MEANINGFUL RESEARCH DATA
Smart Packaging enabled drug products can help
researchers maintain and keep track of research
variables in a more meaningful manner. These
products can form a two-way channel between
participants and researchers, allowing more rapid
and easier collection and transfer of responses
and modification of variables if needed.
7
DIGITAL CONSENT FORMS
Smart drug products can facilitate the collection
of consent forms digitally, making it a smoother
and simpler process for participants in clinical
trials. Participants will have the opportunity to
go through all information, which would be
available digitally through the products smart
packaging, before providing their consent
electronically against that specific dose with
the help of a smartphone.
8
MANAGE CHANGES IN REGULATIONS AND STUDY PROTOCOLS
Life science companies are required to navigate
through and comply with strict and intricate
regulations which are constantly liable to
changes. They also need to deal with changes in
study protocols like expiry dates and IFUs or the
addition of another country for testing during
clinical trials on a regular basis. Giving an
IoT based digital identity to their products
empowers them to easily make updates and changes
to desired products on batch and serial levels,
reducing the need for reprinting and
repackaging.
9
SMART PACKAGING IS GREEN!
Not only will digital labeling facilitate the
distribution of large quantities of information
in easy-to-read formats, but they will also
drastically reduce the volume of materials that
go into producing packaging. By being able to
electronically and remotely update label content,
companies will also be able to cut down on waste
as well as huge costs otherwise incurred due to
repackaging and reprinting.
10
CONSUMER ENGAGEMENT
Smart drug products can forge the bridge that
brings Life science companies closer to their
customers. By digitizing and simplifying label
content for easier consumption by lay people,
they are demonstrating their desire to empower
patients to make better and informed choices
regarding their health. Better informed customers
are more likely to support research, resulting in
better recruitment and retention of participants
for clinical trials.
11
THANK YOU!
For more details visit!
https//www.qliktag.com/future-proofing-clinical-t
rials-management-with-digital-labels-smart-packagi
ng/